SRRT and cancer: Considering that defects in lncRNA-mediated gene regulation contribute to human diseases including cancer and that ARS2 is commonly mutated in various types of cancer, our findings may shed light on pathways contributing to the misexpression of genes, ultimately leading to the development of specific therapeutic strategies.